Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
187.10    0.30 (0.16%)
Bid:
185.70
Ask:
186.20
Spread: 0.50 (0.269%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Pre Stabilisation Notice

1 Jul 2020 11:07

RNS Number : 7204R
HSBC Bank plc
01 July 2020
 

1st July 2020

 

B&M EUROPEAN VALUE RETAIL S.A. 

Pre Stabilisation Notice

HSBC (contact: 'synd manager'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

B&M EUROPEAN VALUE RETAIL S.A.

Guarantor (if any):

na

Aggregate nominal amount:

GBP 350,000,000

Description:

Fixed 2025NC2

Offer price:

TBC /

Other offer terms:

 

Stabilisation:

Stabilising Manager(s):

BNP Paribas, HSBC, Barclays, BoFA, Commerzbank, Goldman Sachs, Lloyds

Stabilisation period expected to start on:

3rd July 2020

Stabilisation period expected to end no later than:

12th August 2020

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

 In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAGZGGNGMDGGZM
Date   Source Headline
17th Jun 202011:38 amRNSDirector/PDMR Shareholding
11th Jun 20207:00 amRNSPreliminary Results
29th May 20207:00 amRNSTrading Update
27th May 20209:57 amRNSHolding(s) in Company
1st Apr 20204:17 pmRNSHolding(s) in Company
1st Apr 202012:29 pmRNSCovid-19 Update
27th Mar 202012:05 pmRNSCompletion of Disposal
25th Mar 20202:50 pmRNSHolding(s) in Company
19th Mar 20202:42 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSDisposal
6th Mar 20206:02 pmRNSSpecial Dividend
3rd Mar 20207:00 amRNSBoard Changes
24th Feb 20209:54 amRNSHolding(s) in Company
14th Jan 202010:10 amRNSHolding(s) in Company
13th Jan 202010:00 amRNSBlock listing Interim Review
10th Jan 20207:00 amRNSTrading Statement
11th Dec 201911:10 amRNSHolding(s) in Company
11th Dec 201911:01 amRNSHolding(s) in Company
2nd Dec 201910:33 amRNSTotal Voting Rights
12th Nov 20197:00 amRNSHalf-year Report
16th Oct 201912:50 pmRNSBoard Retirement
2nd Aug 20193:28 pmRNSDirector/PDMR Shareholding
31st Jul 20199:14 amRNSHolding(s) in Company
29th Jul 201910:40 amRNSResult of AGM
25th Jul 20197:00 amRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSTrading Statement
15th Jul 201912:10 pmRNSBlock listing Interim Review
4th Jul 20199:14 amRNSBlock listing Application
1st Jul 20199:58 amRNSHolding(s) in Company
18th Jun 20198:30 amRNSAnnual Financial Report
4th Jun 201910:37 amRNSDirector/PDMR Shareholding
24th May 201910:33 amRNSDirector/PDMR Shareholding
23rd May 20197:03 amRNSPreliminary Results Announcement
18th Apr 20199:09 amRNSBoard Appointment
25th Feb 201910:16 amRNSDirector/PDMR Shareholding
7th Feb 201912:50 pmRNSDirectorate Change
5th Feb 20191:08 pmRNSDirector/PDMR Shareholding
30th Jan 201910:54 amRNSDirector/PDMR Shareholding
22nd Jan 20199:33 amRNSDirector/PDMR Shareholding
14th Jan 20199:31 amRNSBlock listing Interim Review
10th Jan 20197:00 amRNSTrading Statement
11th Dec 20189:48 amRNSHolding(s) in Company
26th Nov 20189:42 amRNSHolding(s) in Company
13th Nov 20187:00 amRNSHalf-year Report
5th Nov 20189:28 amRNSHolding(s) in Company
19th Oct 20184:35 pmRNSAcquisition of Babou Stores Group in France
10th Oct 201810:27 amRNSHolding(s) in Company
19th Sep 20181:10 pmRNSDirector Declaration
19th Sep 20181:10 pmRNSResult of Ordinary General Meeting
22nd Aug 20182:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.